Submitted by Anonymous (not verified) on 21 August 2026 - 9:51
Human medicines European public assessment report (EPAR): Oxbryta, voxelotor, Date of authorisation: 14/02/2022, Revision: 7, Status: Suspended
Source:
Human medicines European public assessment report (EPAR): Oxbryta, voxelotor, Date of authorisation: 14/02/2022, Revision: 7, Status: Suspended